Research has found that NAD(P)H quinone oxidoreductase 1 mitigates diabetes-induced renal inflammation and fibrosis by modulating the Toll-like receptor 4 (TLR4)/NF-κB and TGF-ß/Smads signaling pathways (Qiu et al., 2023). This evidence concerns the gene TLR4 and inflammatory response.